Trial Profile
Clinical Trials Insight: 700012971
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2006
Price :
$35
*
At a glance
- Drugs Tozasertib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Vertex Pharmaceuticals
- 27 Apr 2006 New trial record.